Cargando…

Multicenter Registry of Patients Receiving Systemic Mold-Active Triazoles for the Management of Invasive Fungal Infections

INTRODUCTION: ‘Real-world’ data for mold-active triazoles (MATs) in the treatment of invasive fungal infections (IFIs) are lacking. This study evaluated usage of MATs in a disease registry for the management of IFIs. METHODS: Data were collected for this multicenter, observational, prospective study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ostrosky-Zeichner, L., Nguyen, M. H., Bubalo, J., Alexander, B. D., Miceli, M. H., Pappas, P. G., Jiang, J., Song, Y., Thompson, G. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334502/ https://www.ncbi.nlm.nih.gov/pubmed/35716251 http://dx.doi.org/10.1007/s40121-022-00661-5

Ejemplares similares

Real-world Use of Mold-Active Triazole Prophylaxis in the Prevention of Invasive Fungal Diseases: Results From a Subgroup Analysis of a Multicenter National Registry
por: Nguyen, M Hong, et al.
Publicado: (2023)

Investigational Agents for the Treatment of Resistant Yeasts and Molds
por: Seiler, Garret T., et al.
Publicado: (2021)

Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases
por: Thompson, George R, et al.
Publicado: (2022)

Coronavirus Disease 2019–Associated Invasive Fungal Infection
por: Baddley, John W, et al.
Publicado: (2021)

1718. Rezafungin Clinical Safety and Efficacy in Patients With Candidemia and/or Invasive Candidiasis in the Randomized, Double-Blind, Multicenter, Phase 2 STRIVE Study
por: Thompson, George R, et al.
Publicado: (2018)

Invasive Mold Infections Following Hurricane Harvey—Houston, Texas
por: Toda, Mitsuru, et al.
Publicado: (2023)

Clinical prediction rules for invasive candidiasis in the ICU: ready for prime time?
por: Ostrosky-Zeichner, Luis
Publicado: (2011)

Prevention and Treatment of Yeast and Endemic Fungal Infections
por: Al Hammadi, Ahmed, et al.
Publicado: (2019)

SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients
por: Montagna, M. T., et al.
Publicado: (2013)

Hurricane-Associated Mold Exposures Among Patients at Risk for Invasive Mold Infections After Hurricane Harvey — Houston, Texas, 2017
por: Chow, Nancy A., et al.
Publicado: (2019)

2252. Patient Preferences for Triazole Antifungals in the Treatment of Invasive Mold Infection: A Discrete Choice Experiment
por: Bhagat, Hardik, et al.
Publicado: (2019)

Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT1): A Prospective, Multicenter Study of the T2Candida Panel
por: Clancy, Cornelius J, et al.
Publicado: (2017)

Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial
por: Perfect, John R., et al.
Publicado: (2018)

969. Outbreak of Fungal Meningitis in US Patients who Received Surgical Procedures under Epidural Anesthesia in Matamoros, Mexico
por: Smith, Dallas J, et al.
Publicado: (2023)

971. Breakthrough Invasive Fungal Infections (IFI) in Acute Leukemia (AL) Patients Receiving Antifungal Prophylaxis
por: Wasylyshyn, Anastasia, et al.
Publicado: (2018)

369. Using Hybrid Models and Blockchain Technology as a Means to Develop a Novel Propensity Score for Candidemia and Invasive Candidiasis
por: Rao, Arni Sr Srinivasa, et al.
Publicado: (2018)

Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial
por: Thompson, George R, et al.
Publicado: (2020)

Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance
por: Ellsworth, Misti, et al.
Publicado: (2020)

2045. Pitfalls in the Use of MALDI TOF Mass Spectrometry for the Identification of Problematic Yeast Isolates from a Historical Collection
por: Pachar, Monica, et al.
Publicado: (2018)

1248. Efficacy and Safety of Oral Ibrexafungerp in 41 Patients with Refractory Fungal Diseases, Interim Analysis of a Phase 3 Open-label Study (FURI)
por: Alexander, Barbara D, et al.
Publicado: (2020)

Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B
por: Dupont, Bertrand F, et al.
Publicado: (2009)

Central Nervous System Infections Due to Aspergillus and Other Hyaline Molds
por: Miceli, Marisa H.
Publicado: (2019)

1196. Is the Weekend Staff Really to Blame? Challenges in Isolation Compliance at an Academic Tertiary Care Center
por: Bassett, Sonia, et al.
Publicado: (2019)

QTc Prolongation in Patients Receiving Triazoles and Amiodarone
por: Cook, Katherine, et al.
Publicado: (2017)

Drunk Without Drinking: A Case of Auto-Brewery Syndrome
por: Akhavan, Bobak J., et al.
Publicado: (2019)

123. Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI)
por: Pappas, Peter G, et al.
Publicado: (2021)

Mind the gap: The hospital breakroom
por: Ellsworth, Misti, et al.
Publicado: (2020)

Invasive Non-Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006
por: Park, Benjamin J., et al.
Publicado: (2011)

Chronic Illness Associated with Mold and Mycotoxins: Is Naso-Sinus Fungal Biofilm the Culprit?
por: Brewer, Joseph H., et al.
Publicado: (2013)

Post-exposure prophylaxis with isavuconazole after occupational exposure to Rhizopus
por: Al-Obaidi, Mohanad, et al.
Publicado: (2018)

Outpatient Infection Prevention: A Practical Primer
por: Steinkuller, Fozia, et al.
Publicado: (2018)

Safety and efficacy of liposomal amphotericin B for the empirical therapy of invasive fungal infections in immunocompromised patients
por: Miceli, Marisa H, et al.
Publicado: (2012)

Trends of Azole Antifungal Prescription in the United States: Medicare Part D Provider Utilization and Payment Data Analysis
por: Al-Obaidi, Mohanad M, et al.
Publicado: (2023)

Incidence and Risk Factors for Breakthrough Invasive Mold Infections in Acute Myeloid Leukemia Patients Receiving Remission Induction Chemotherapy
por: Patel, Heena P, et al.
Publicado: (2019)

2419. Increasing Misattribution of Bacteremia as CLABSIs by NHSN Definitions: A Tertiary Care Center Perspective
por: Ellsworth, Misti G, et al.
Publicado: (2023)

Diagnosis of Pneumonia Due to Invasive Molds
por: Foppiano Palacios, Carlo, et al.
Publicado: (2021)

Diagnosis and Treatment of Invasive Mold Diseases
por: Lee, Sang-Oh
Publicado: (2023)

Invasive Fungal Disease in Patients with Newly Diagnosed Acute Myeloid Leukemia
por: Wasylyshyn, Anastasia I., et al.
Publicado: (2021)

1623. Implementation of Electronic Readmission Alert for Discharged Patients Reduces Risk of Secondary Measles Exposure Events
por: Boston, Kelley M, et al.
Publicado: (2019)

Palonosetron in the management of chemotherapy-induced nausea and vomiting in patients receiving multiple-day chemotherapy
por: Affronti, Mary Lou, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4qdlv6v6ku5ssh7aamuvljiu6a